Geron Corp. buy Slaandjivaa
Start price
16.01.18
/
50%
€1.94
Target price
01.03.18
€2.26
Performance (%)
8.12%
End price
01.03.18
€2.10
Summary
This prediction ended on 01.03.18 with a price of €2.10. The BUY prediction by Slaandjivaa finished with a performance of 8.12%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Geron Corp. | -2.858% | -2.858% | 57.004% | 291.272% |
iShares Core DAX® | -5.744% | -6.037% | 9.155% | 8.257% |
iShares Nasdaq 100 | -4.907% | -12.083% | 19.607% | 30.219% |
iShares Nikkei 225® | -7.230% | -10.182% | 3.445% | -1.121% |
iShares S&P 500 | -4.764% | -6.545% | 19.194% | 31.957% |
Comments by Slaandjivaa for this prediction
In the thread Geron Corp. diskutieren
Gerne Geron
https://seekingalpha.com/article/4137225-toxicity-gerons-imetelstat-may-lead-accelerated-fda-approval
(Vom Mitglied beendet)